HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Pietra Selected Research

CHF 2819

8/2003Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells.
8/2001Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels.
7/2000Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Pietra Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
08/2001 - 01/2000
2Constipation
12/2015 - 12/2014
2Parkinson Disease (Parkinson's Disease)
12/2015 - 12/2014
2Body Weight (Weight, Body)
09/2013 - 07/2000
2Seizures (Absence Seizure)
09/2001 - 06/2001
1Overactive Urinary Bladder (Overactive Bladder)
03/2014
1Anorexia
09/2013
1Cachexia
09/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2013
1Lung Neoplasms (Lung Cancer)
09/2013
1Neoplasms (Cancer)
09/2013
1Neuroblastoma
08/2003
1Epilepsy (Aura)
09/2001
1Brain Ischemia (Cerebral Ischemia)
05/2001
1Ischemia
05/2001
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2001
1Depressive Disorder (Melancholia)
07/2000
1Cognitive Dysfunction
07/2000
1Amnesia (Dissociative Amnesia)
07/2000

Drug/Important Bio-Agent (IBA)

3CHF 2819IBA
08/2003 - 07/2000
2Ghrelin ReceptorsIBA
12/2015 - 09/2013
2HM01IBA
12/2015 - 12/2014
2N-Methylaspartate (NMDA)IBA
09/2001 - 06/2001
2Rivastigmine (Exelon)FDA LinkGeneric
08/2001 - 05/2000
2Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2001 - 07/2000
1Levodopa (L Dopa)FDA LinkGeneric
12/2014
1Oxidopamine (6 Hydroxydopamine)IBA
12/2014
1Neurokinin-1 Receptor AntagonistsIBA
03/2014
1netupitantIBA
03/2014
1anamorelinIBA
09/2013
1Insulin (Novolin)FDA Link
09/2013
1GhrelinIBA
09/2013
1geneserineIBA
08/2003
1ganstigmineIBA
08/2003
1AcetylcholinesteraseIBA
08/2003
1Amyloid (Amyloid Fibrils)IBA
08/2003
1Proteins (Proteins, Gene)FDA Link
08/2003
1Pharmaceutical PreparationsIBA
09/2001
1SpermidineIBA
09/2001
1indantadolIBA
09/2001
1Dizocilpine Maleate (Dizocilpine)IBA
09/2001
1LigandsIBA
09/2001
1glycine amideIBA
09/2001
1Excitatory Amino Acid AntagonistsIBA
09/2001
1Amino AcidsFDA Link
08/2001
1BicucullineIBA
06/2001
1PicrotoxinIBA
06/2001
1triphenyltetrazoliumIBA
05/2001
1SaltsIBA
05/2001
1SodiumIBA
05/2001
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2001
13- (2- ((phenylamino)carbonyl)ethenyl)- 4,6- dichloroindole- 2- carboxylic acidIBA
05/2001
1Glycine Receptors (Glycine Receptor)IBA
05/2001
1Carboxylic AcidsIBA
05/2001
1Scopolamine (Hyoscine)FDA Link
07/2000
1Cholinergic Agents (Cholinergics)IBA
07/2000
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2000
14-Aminopyridine (4 Aminopyridine)FDA Link
01/2000
1Ion Channels (Ion Channel)IBA
01/2000
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2000

Therapy/Procedure

1Oral Administration
09/2001